CIK 0001404281 · Non-accelerated filer<br>Smaller reporting company
Eledon Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ELDN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 949-238-8090
- Business address
- 19800 MACARTHUR BLVD., SUITE 250, IRVINE, CA, 92612
- Former names
- Eledon Pharmaceuticals, Inc., Novus Therapeutics, Inc., Tokai Pharmaceuticals Inc
- 4 Open-market sale 10% owner sold 103,200 shares at $21.60 ($2,229,120)
- SC 13D/A Stake Beneficial Ownership Report
- UPLOAD Other SEC-generated Letter
- SC 13D/A Stake Beneficial Ownership Report
- 8-K Event Bylaws or fiscal year change
- 8-K/A Event Exhibits
- DEF 14A Proxy Proxy Statement
- 10-Q Report Quarterly Report
- CORRESP Other Correspondence Between Filers and SEC Staff
- PRER14A Other PRER14A
- SC 13G Stake Amended Statement of Ownership
- UPLOAD Other SEC-generated Letter
- 4 Open-market buy 10% owner bought 92,040 shares at an average $25.44 ($2,341,714)
- 3 Insider Initial Statement of Ownership
- PRE 14A Proxy Proxy Statement (Preliminary)
- SC 13D/A Stake Beneficial Ownership Report
- 8-K Event Bylaws or fiscal year change
- 3 Insider Initial Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- D Other Notice of Sales of Unregistered Securities
Page 14 of 31 · 616 filings